Puma Biotechnology Sees Q3 Revenue $51M-$53M Vs $60.49M Est
Portfolio Pulse from Benzinga Newsdesk
Puma Biotechnology has projected its Q3 revenue to be between $51M-$53M, which is lower than the estimated $60.49M.
August 04, 2023 | 2:49 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Puma Biotechnology's projected Q3 revenue is lower than the estimated $60.49M, which could negatively impact its stock price.
Puma Biotechnology's lower than expected Q3 revenue projection could lead to a decrease in investor confidence, potentially causing a drop in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100